314 related articles for article (PubMed ID: 26365781)
1. Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo.
Van Hove AH; Burke K; Antonienko E; Brown E; Benoit DS
J Control Release; 2015 Nov; 217():191-201. PubMed ID: 26365781
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides.
Van Hove AH; Beltejar MJ; Benoit DS
Biomaterials; 2014 Dec; 35(36):9719-30. PubMed ID: 25178558
[TBL] [Abstract][Full Text] [Related]
3. Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels.
Van Hove AH; Antonienko E; Burke K; Brown E; Benoit DS
Adv Healthc Mater; 2015 Sep; 4(13):2002-11. PubMed ID: 26149620
[TBL] [Abstract][Full Text] [Related]
4. In situ SVVYGLR peptide conjugation into injectable gelatin-poly(ethylene glycol)-tyramine hydrogel via enzyme-mediated reaction for enhancement of endothelial cell activity and neo-vascularization.
Park KM; Lee Y; Son JY; Bae JW; Park KD
Bioconjug Chem; 2012 Oct; 23(10):2042-50. PubMed ID: 22998168
[TBL] [Abstract][Full Text] [Related]
5. Poly(N-isopropylacrylamide)-based dual-crosslinking biohybrid injectable hydrogels for vascularization.
Pal A; Smith CI; Palade J; Nagaraju S; Alarcon-Benedetto BA; Kilbourne J; Rawls A; Wilson-Rawls J; Vernon BL; Nikkhah M
Acta Biomater; 2020 Apr; 107():138-151. PubMed ID: 32126310
[TBL] [Abstract][Full Text] [Related]
6. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.
Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D
Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963
[TBL] [Abstract][Full Text] [Related]
7. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide.
Young DA; Pimentel MB; Lima LD; Custodio AF; Lo WC; Chen SC; Teymour F; Papavasiliou G
Biomater Sci; 2017 Sep; 5(10):2079-2092. PubMed ID: 28744527
[TBL] [Abstract][Full Text] [Related]
9. Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels.
He X; Ma J; Jabbari E
Int J Pharm; 2010 May; 390(2):107-16. PubMed ID: 20219655
[TBL] [Abstract][Full Text] [Related]
10. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
11. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Zieris A; Chwalek K; Prokoph S; Levental KR; Welzel PB; Freudenberg U; Werner C
J Control Release; 2011 Nov; 156(1):28-36. PubMed ID: 21763368
[TBL] [Abstract][Full Text] [Related]
12. Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels.
Mulyasasmita W; Cai L; Hori Y; Heilshorn SC
Tissue Eng Part A; 2014 Aug; 20(15-16):2102-14. PubMed ID: 24490588
[TBL] [Abstract][Full Text] [Related]
13. Integrin-specific hydrogels functionalized with VEGF for vascularization and bone regeneration of critical-size bone defects.
García JR; Clark AY; García AJ
J Biomed Mater Res A; 2016 Apr; 104(4):889-900. PubMed ID: 26662727
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of primary salivary gland cells in enzymatically degradable poly(ethylene glycol) hydrogels promotes acinar cell characteristics.
Shubin AD; Felong TJ; Schutrum BE; Joe DSL; Ovitt CE; Benoit DSW
Acta Biomater; 2017 Mar; 50():437-449. PubMed ID: 28039063
[TBL] [Abstract][Full Text] [Related]
15. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
16. Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration.
Silva CR; Babo PS; Gulino M; Costa L; Oliveira JM; Silva-Correia J; Domingues RMA; Reis RL; Gomes ME
Acta Biomater; 2018 Sep; 77():155-171. PubMed ID: 30031163
[TBL] [Abstract][Full Text] [Related]
17. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
18. Pro-angiogenic near infrared-responsive hydrogels for deliberate transgene expression.
Martín-Saavedra F; Escudero-Duch C; Prieto M; Sánchez-Casanova S; López D; Arruebo M; Voellmy R; Santamaría J; Vilaboa N
Acta Biomater; 2018 Sep; 78():123-136. PubMed ID: 30098440
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.
Koetting MC; Guido JF; Gupta M; Zhang A; Peppas NA
J Control Release; 2016 Jan; 221():18-25. PubMed ID: 26616761
[TBL] [Abstract][Full Text] [Related]
20. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.
Wang Y; Zhang S; Benoit DSW
J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]